Work

Clinical Outcomes of the MYNX CONTROLTM Vascular Closure Device ― A Multicenter Clinical Trial in Japan ―

Year: 2026

Type: article

Abstract: Background: Vascular closure devices have become standard for hemostasis following the transfemoral approach. The MYNX CONTROL Vascular Closure Device is a percutaneous closure system that delivers a biocompatible, polyethylene glycol-based, water-soluble sealant for extravascular hemostasis. This study evaluated the efficacy and safety of the MYNX CONTROL device for femoral artery puncture site hemostasis in Japanese patients.

Source: Circulation Reports

DOI: 10.1253/circrep.cr-26-0260

Authors: Taku Toyoshima, Osamu Iida, Daizo Kawasaki, Masahiko Fujihara, Naoki Hayakawa, Toshiaki Mano, Yoshimitsu Soga, Kenji Ando, Yoshiharu Higuchi, Fumiyuki Hayashi, Akira Miyamoto, Masato Nakamura

Institutions: Osaka Police Hospital, Morinomiya Hospital, Kishiwada Tokushukai Hospital, Asahi General Hospital, Kansai Rosai Hospital, Kokura Memorial Hospital, Toho University Ohashi Medical Center, Takatsuki General Hospital

Language: English

Topic: Vascular Procedures and Complications

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7221956958

FWCI:

Cites:

Cited by:

Related to: